Synergistic Enteral Regimen for Treatment of the Gangliosidoses

NCT02030015 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

16

Enrollment

OTHER

Sponsor class

Stopped Efficacy

Conditions

GM1 Gangliosidoses
GM2 Gangliosidoses
Tay-Sachs Disease
Sandhoff Disease

Interventions

DRUG: miglustat
OTHER: Ketogenic Diet

Sponsor

University of Minnesota

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]